Wendy’s (WEN) shares are in the spotlight on Thursday after the fast-food chain formally rejected a $1.4 billion takeover proposal led by activist investor Nelson Peltz’s Trian Fund Management. The company said Trian’s bid “significantly undervalues” its long-term prospects and the potential upside from its ongoing turnaround strategy.
The investor group had offered to acquire Wendy’s at $7.35 per share in cash. However, Wendy's independent committee of directors unanimously concluded that the proposal failed to reflect the chain’s future earnings potential.
WEN stock is currently down about 15% versus its year-to-date high.
Wendy’s Resorts to a Poison Pill to Avoid Hostile Takeover
Rejecting Peltz’s buyout proposal suggests management believes the company is worth more as a standalone business. It also signals confidence in the turnaround initiative, which includes menu upgrades, operational improvements, and efforts to restore traffic growth.
However, to avoid a hostile takeover, WEN resorted to a shareholder rights plan, widely known as the poison pill, which would dilute not only Trian’s stake but non-participating existing investors as well.
Wendy’s stock has its relative strength index (RSI) set at about 69 currently, indicating it’s now hovering around overbought territory, which often triggers a near-term selloff.
What Rejecting Peltz’s Proposal Means for WEN Investors
While Wendy’s board had the liberty of betting on potential, its investors must live with the reality. And the reality is that the company’s same-store sales were down 5.7% in its third fiscal quarter, extending a lengthy streak of declines.
On Thursday, WEN reported better-than-expected profit and revenue for its Q3, but the same-store weakness suggests its underlying demand challenges are yet to be resolved. So the fast-food chain is essentially asking its shareholders to believe in and finance its multi-year turnaround plan — the outcome of which remains far from guaranteed.
What’s the Consensus Rating on Wendy’s?
Crucially, Wall Street analysts aren’t convinced that Wendy’s shares could be worth more, at least in the near term, than the price at which they’re trading already.
The consensus rating on WEN sits at “Hold” only, with the mean price target of about $7.38 signaling potential downside of about 4% from here.
On the date of publication, Wajeeh Khan did not directly have a position in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.